Pharmaceuticals Stocks

Vertex Pharmaceuticals Inc Valuation – February 2019 $VRTX

Vertex Pharmaceuticals Incorporated does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the insufficient earnings stability or growth over the last ten years, and the poor dividend history, and the high PEmg and PB ratios.

Read More
Pharmaceuticals Stocks

Vertex Pharmaceuticals Inc Valuation – April 2018 $VRTX

Vertex Pharmaceuticals Incorporated does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the insufficient earnings stability or growth over the last ten years, and the poor dividend history, and the high PEmg and PB ratios.

Read More
Pharmaceuticals Stocks

Vertex Pharmaceuticals Inc Valuation – August 2016 $VRTX

Vertex Pharmaceuticals Incorporated does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the insufficient earnings stability or growth over the last ten years, the poor dividend history, and the high PEmg and PB ratios.

Read More
Back To Top